發(fā)布時(shí)間：2018-08-28 15:37

【摘要】：目的:通過(guò)對(duì)中醫(yī)辨證屬風(fēng)熱郁肺證和痰熱閉肺證的肺炎支原體肺炎患兒在阿奇霉素治療的基礎(chǔ)上,予蒿芩麻杏石甘湯口服及拔罐治療,與單用阿奇霉素抗感染治療作對(duì)比,觀察罐藥綜合治療肺炎支原體肺炎療效及安全性,并對(duì)其進(jìn)行綜合評(píng)價(jià)。方法:本研究選取北京中醫(yī)藥大學(xué)東方醫(yī)院門診及病房收治肺炎支原體肺炎患兒共100例,所選患兒均符合肺炎支原體肺炎西醫(yī)診斷,中醫(yī)診斷為肺炎喘嗽,證屬風(fēng)熱郁肺或痰熱閉肺證。隨機(jī)分為實(shí)驗(yàn)組和對(duì)照組,對(duì)照組予阿奇霉素抗感染治療及對(duì)癥支持治療,實(shí)驗(yàn)組在對(duì)照組治療的基礎(chǔ)上予蒿芩麻杏石甘湯口服與拔罐治療,在特定時(shí)間點(diǎn)對(duì)兩組患兒主要癥狀(咳嗽、痰壅、發(fā)熱、氣喘、肺部Up音)、次要癥狀(食欲、惡心、精神、面色),實(shí)驗(yàn)室指標(biāo)及療效評(píng)價(jià)指標(biāo)評(píng)分,評(píng)價(jià)蒿芩麻杏石甘湯配合拔罐治療的臨床療效。結(jié)果:實(shí)驗(yàn)組與對(duì)照組的組內(nèi)總分比較,治療前后均有明顯差異,病情分級(jí)差異明顯,提示兩組治療均有效。組間比較,兩組治療后癥狀評(píng)分無(wú)明顯區(qū)別,兩組治療后實(shí)驗(yàn)室檢查無(wú)明顯差異,但實(shí)驗(yàn)組主癥起效時(shí)間評(píng)分明顯高于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義,且在咳嗽、痰壅、聽(tīng)診起效時(shí)間上明顯高于對(duì)照組,提示實(shí)驗(yàn)組在咳嗽好轉(zhuǎn)時(shí)間、痰壅好轉(zhuǎn)時(shí)間及Up音吸收時(shí)間短于對(duì)照組。實(shí)驗(yàn)組痊顯率94%明顯高于對(duì)照組78%,治療后實(shí)驗(yàn)組癥狀總分較對(duì)照組更低,治療后病情分級(jí)實(shí)驗(yàn)組明顯優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義,提示實(shí)驗(yàn)組治療計(jì)劃更優(yōu)。結(jié)論:罐藥綜合療法治療肺炎支原體肺炎可提高痊顯率,更快改善咳嗽、咳痰癥狀,促進(jìn)Up音吸收,療效明顯,使用安全。
[Abstract]:Objective: based on the treatment of azithromycin, the children with mycoplasma pneumoniae pneumonia with syndrome differentiation of wind-heat depression lung syndrome and phlegm-heat blocking lung syndrome were treated with Azithromycin orally and cupping, and compared with azithromycin alone. To observe the efficacy and safety of combined treatment of mycoplasma pneumoniae pneumonia with cupping drugs, and to evaluate it synthetically. Methods: a total of 100 children with mycoplasma pneumoniae pneumonia were selected from the outpatient and ward of Oriental Hospital of Beijing University of traditional Chinese Medicine. The syndrome is wind heat depression lung or phlegm heat block lung syndrome. The experimental group was randomly divided into experimental group and control group. The control group was treated with azithromycin anti-infective therapy and symptomatic support therapy. The experimental group was treated with Azithromycin Maxingshigan decoction orally and cupping on the basis of the treatment in the control group. The main symptoms (cough, phlegm obstruction, fever, asthma, lung Up sound), secondary symptoms (appetite, nausea, spirit, complexion), laboratory indexes and therapeutic evaluation indexes were evaluated at a specific time point in the two groups. To evaluate the clinical effect of Aoqingma Xingshigan decoction combined with cupping. Results: compared with the control group, the total scores of the experimental group and the control group were significantly different before and after treatment, indicating that the two groups were effective. There was no significant difference in the scores of symptoms between the two groups after treatment, and there was no significant difference in laboratory examination between the two groups, but the scores of the onset time of the main symptoms in the experimental group were significantly higher than those in the control group, and the difference was statistically significant in cough and phlegm obstruction. The effect time of auscultation was significantly higher than that of the control group, suggesting that the time of cough improvement, phlegm accumulation and Up tone absorption were shorter in the experimental group than in the control group. After treatment, the total score of symptoms in the experimental group was lower than that in the control group, and the disease grade in the experimental group was significantly better than that in the control group after treatment. The difference was statistically significant, suggesting that the treatment plan of the experimental group was better than that of the control group. Conclusion: the treatment of mycoplasma pneumoniae pneumonia with combined cupping therapy can improve the cure rate, improve cough and expectoration symptoms, promote the absorption of Up sound, and is safe to use.
【學(xué)位授予單位】：北京中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R272

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 郭寬鵬;;微生物快速培養(yǎng)檢測(cè)在肺炎患兒支原體感染診斷中的應(yīng)用[J];中國(guó)醫(yī)學(xué)工程;2017年02期

2 謝克強(qiáng);;紅霉素聯(lián)合阿奇霉素序貫療法對(duì)支原體肺炎患兒免疫功能、心肌酶譜及治療效果的影響[J];中國(guó)醫(yī)學(xué)工程;2017年02期

3 付明利;李宏偉;;146例兒童支原體肺炎臨床特點(diǎn)分析[J];醫(yī)學(xué)理論與實(shí)踐;2017年04期

4 唐青松;;小兒肺炎支原體肺炎臨床治療研究[J];中國(guó)社區(qū)醫(yī)師;2017年04期

5 龔亞?wèn)|;林牧;馬慶慶;王芳;;3種方法檢測(cè)128例兒童肺炎支原體感染結(jié)果分析[J];中國(guó)社區(qū)醫(yī)師;2017年02期

6 王秀芳;胡文潔;宋麗;宋哲;;不同年齡段難治性肺炎支原體肺炎急性期患兒纖維支氣管鏡下氣道改變特點(diǎn)[J];中國(guó)婦幼保健;2017年03期

7 劉艷;黃澤智;蒙松年;唐翠連;;肺炎支原體對(duì)紅霉素體外耐藥性與耐藥基因相關(guān)性研究[J];國(guó)際檢驗(yàn)醫(yī)學(xué)雜志;2017年02期

8 龔亞?wèn)|;馬慶慶;林牧;;兒童肺炎支原體感染3種檢測(cè)方法對(duì)比分析[J];現(xiàn)代醫(yī)藥衛(wèi)生;2017年02期

9 計(jì)晨琳;;肺炎支原體感染對(duì)患兒細(xì)胞免疫和肺功能的影響及其相關(guān)性分析[J];臨床合理用藥雜志;2017年03期

10 張戰(zhàn)軍;;肺炎支原體感染患兒的臨床檢驗(yàn)結(jié)果分析及其治療[J];臨床合理用藥雜志;2017年03期

相關(guān)會(huì)議論文 前1條

1 潘璐;安效先;;安效先教授治療小兒支原體肺炎經(jīng)驗(yàn)[A];北京中醫(yī)藥學(xué)會(huì)2012年學(xué)術(shù)年會(huì)論文匯編[C];2012年

相關(guān)碩士學(xué)位論文 前4條

1 田國(guó)治;兒童支原體肺炎凝血狀態(tài)的研究[D];山西醫(yī)科大學(xué);2016年

2 張麗萍;敷胸外治法干預(yù)小兒肺炎的主要癥狀體征療效分析[D];遼寧中醫(yī)藥大學(xué);2015年

3 戴志國(guó);中醫(yī)內(nèi)外合治小兒肺炎喘嗽臨床療效研究[D];北京中醫(yī)藥大學(xué);2012年

4 陳鵬;小兒肺炎的診治研究進(jìn)展及不同病原小兒肺炎中醫(yī)證型的分布規(guī)律研究[D];成都中醫(yī)藥大學(xué);2006年

，

本文編號(hào)：2209844